ã¡ãã£ã¢èšäº
æ°åãŠã€ã«ã¹ã®çµå£æ²»çè¬ãå
¥é¢ã»æ»äº¡ãªã¹ã¯ãåæžã米補è¬äŒç€Ÿãç·æ¥äœ¿çšç³è«ãž
ããºãææ°ããŒã¯ 156
twitterã³ã¡ã³ã 61ä»¶äž 1ïœ61件
ãããªèšäºããããŸãã
å€ãªåå(ŽÏ`)
é å€åã®COVID-19ã®çµå£æ²»çè¬ãã¢ã«ããã©ãã«ã
é å€åã®COVID-19ã®çµå£æ²»çè¬ãã¢ã«ããã©ãã«ã
ããããŠ
ããã§ããšæ³šå°ã§ã¯ãªãçµå£æ²»çè¬ïŒããŠãã©ïœïœãªãããª
ãæ¿èªãããã°ãã¢ã«ããã©ãã«ã¯COVID-19ã®åã®çµå£æãŠã€ã«ã¹è¬ãšãªãã
ãäžäœæåŸåœã«ã¢ã«ããã©ãã«ãäŸçµŠããããã«âŠã
ãäžäœæåŸåœã«ã¢ã«ããã©ãã«ãäŸçµŠããããã«âŠã
ã¡ã«ã¯ãã...ã¡ãã£ã¢ã奜æçã«åãäžããŠããæç¹ã§æççããã¡ãŠãã®ã³ã¡ã³ããããã®ãæ°ã«å
¥ããªããç¹ã«ããã§ã«é床ã®COVID-19ã§å
¥é¢ããŠããæ£è
ã察象ãšããåæç 究ã§ã¯ãäžæ¬æãªçµæãšãªããç 究ã¯äžæ¢ãããããã£ãŠãªã€ïŒçµ¶å¯Ÿã«ãããããããªããã
è¯ãçµå£æ²»çè¬ãããããæ¿èªããããã§ãã
ããŸã å¹æã®ããããªãã€ãã«ã¡ã¯ãã³ã¯ãããæ¹ãããã§ããããã¯ã¯ãã³æ¥çš®ãåããã°å¿ èŠã®ãªãè¬ã§ããã
ããŸã å¹æã®ããããªãã€ãã«ã¡ã¯ãã³ã¯ãããæ¹ãããã§ããããã¯ã¯ãã³æ¥çš®ãåããã°å¿ èŠã®ãªãè¬ã§ããã
çæã¡ã«ã¯ãã¢ã«ããã©ãã«ãæ ªäŸ¡ã¯ãããªãã®
è¥æºè éçåã¡ã«ããºã ãåãå§ãããããŸãå¹ããªããããããã50ïŒ å¹æãèšåºã§ãããªããå幎挞æžã®ã¯ã¯ããããå¯äœçšæ¬¡ç¬¬ã ã奜ãŸããããªãå°å ¥ã®ãã®å®æãã¯ãšããããã
è¥æºè éçåã¡ã«ããºã ãåãå§ãããããŸãå¹ããªããããããã50ïŒ å¹æãèšåºã§ãããªããå幎挞æžã®ã¯ã¯ããããå¯äœçšæ¬¡ç¬¬ã ã奜ãŸããããªãå°å ¥ã®ãã®å®æãã¯ãšããããã
ããŠã€ã«ã¹ãèªåèªèº«ã®ã³ããŒãäœãéã«äœ¿ãé
µçŽ ãæšçãšããããšã§å¹æãçºæ®ããã
ãªãã»ã©ãã¢ã©ãã«ãã«ã¯ããŠã£ã«ã¹ç±æ¥ã®RNA-RNA転åé µçŽ ãæšçã«è»¢åå¹²æžããŠãŠã£ã«ã¹RNAã«åŒ·å¶çã«å€ç°ãå ¥ããè¬ããçªç¶å€ç°ä»¥äžã®é »åºŠã§å€ç°æ¿å ¥ããŠãŠã£ã«ã¹RNAã®ç¡ååãã
ãªãã»ã©ãã¢ã©ãã«ãã«ã¯ããŠã£ã«ã¹ç±æ¥ã®RNA-RNA転åé µçŽ ãæšçã«è»¢åå¹²æžããŠãŠã£ã«ã¹RNAã«åŒ·å¶çã«å€ç°ãå ¥ããè¬ããçªç¶å€ç°ä»¥äžã®é »åºŠã§å€ç°æ¿å ¥ããŠãŠã£ã«ã¹RNAã®ç¡ååãã
ç·æ¥äœ¿çšç³è«ãšã¯ãèªå¯åã«äœ¿çšåºæ¥ãã³ãããŠã€ã«ã¹ææç察ç倧統é 什(çºä»€è
ïŒïŒä»£ã¢ã¡ãªã«å€§çµ±é )ã«äŸãç©ã§ãããã
å°ã³ããã¯ã¯ãã³ãç·æ¥äœ¿çšç¹äŸæªçœ®ãååœã§å»ããŠããŸãã
å°ã³ããã¯ã¯ãã³ãç·æ¥äœ¿çšç¹äŸæªçœ®ãååœã§å»ããŠããŸãã
ã¢ã«ããã©ãã«äœèªã ãã
ã¢ã«ããã©ãã«ã¯ãŠã€ã«ã¹ã®éºäŒåã«å¯ŸããŠè€è£œãšã©ãŒãçããããå¢æ®ãé²ãããèšèšãããŠãããšã®ããšããªãã ãåŸäœãç¥ããªãããå¯äœçšã匷ãããªã®ã«ãªãèšäºã«æžãããªãã®ããªïŒ
ã¢ãã¬ã³ã¯èå ã«å¥åœ¢ãçããå¯èœæ§ããããšãæ£ã èšãããã®ã«ã
ã¢ãã¬ã³ã¯èå ã«å¥åœ¢ãçããå¯èœæ§ããããšãæ£ã èšãããã®ã«ã
é²æ©ãããããªãŒ
ãã®ã³ããæ²»çã®ããã®é£²ã¿è¬ïŒã¢ãã«ãã©ãã«ïŒãç§ãåšç±ããŠãã倧åŠã®ç 究è
ãçºèŠãããã£ãŠåŠå
ã¡ãŒã«ãéãããŠããŸããã
åœåã¯EIDD-2801ãšåœåãããŠããããã§ãã
ã¢ã¡ãªã«ã®å€§åŠã£ãŠãããŒïŒèªåœåïŒ
åœåã¯EIDD-2801ãšåœåãããŠããããã§ãã
ã¢ã¡ãªã«ã®å€§åŠã£ãŠãããŒïŒèªåœåïŒ
ããã¯ããå¿
é ã§ããã
ãã æè¿ããã¿ãã¢ã«ããã©ãã«ã¯æãŠã€ã«ã¹è¬ãªã®ã§ãçºçæãããªãã¹ãæ©ã飲ãŸãªããšãããªããšèšã...
çç¶ãåºããšæã£ããæ©ãã«æ€æ»ããŠè¬ãå ¥æã§ãããè¿ éãªå»çã¢ã¯ã»ã¹ãå¿ èŠããªãš
ãã æè¿ããã¿ãã¢ã«ããã©ãã«ã¯æãŠã€ã«ã¹è¬ãªã®ã§ãçºçæãããªãã¹ãæ©ã飲ãŸãªããšãããªããšèšã...
çç¶ãåºããšæã£ããæ©ãã«æ€æ»ããŠè¬ãå ¥æã§ãããè¿ éãªå»çã¢ã¯ã»ã¹ãå¿ èŠããªãš
ããã»ã©ã®ã¡ã«ã¯ç€Ÿ ã«ã€ããŠã
BBC JAPANããã
BBC JAPANããã
ãããããçµå£æ²»çè¬ã幎å
ã«ããïŒ
åéãå®å
šåŠå®ã¯ããŠããªããã©ã³ããã«ã¯åŠå®çãªã€ãã«ã¡ã¯ãã³ããããã£ã¡ã®ã»ããæåŸ
倧ã§ããã
ãã®è¬ã¯ããšããšã€ã³ãã«ãšã³ã¶æ²»çè¬ãšããŠéçºããããã®ã§ããŠã€ã«ã¹ã®éºäŒåã«å¯ŸããŠè€è£œãšã©ãŒãçããããå¢æ®ãé²ãããèšèšãããŠããã
ããããã³ããéšåãçµãããèŠããŠæ¥ãããð
ãã®é ã«ã¯ã¢ã¡ãªã«ã®ãœãŒã»ãŒãžãåºåã£ãŠã¯ã¯ãã³äžèŠã«ãªãããïŒ
ã¬ã ãã·ãã«çãšã¯æ¯èŒã§ããªãã»ã©åªããçµæã
ãã®çµæã§ç¹å¹è¬ãšåŒã¶äººãããŠãæ¹å€ããã€ããã¯ãªããã©ãããã§ããããããããããææããŠã¿ãŠå€§äžå€«ãã§ã¯ãªããã ãã
ãã ãä»åŸã®ç 究次第ã§ã¿ããªãæããããªæå³ã§ã®ç¹å¹è¬ã«ãªããããããªãã
ãã®çµæã§ç¹å¹è¬ãšåŒã¶äººãããŠãæ¹å€ããã€ããã¯ãªããã©ãããã§ããããããããããææããŠã¿ãŠå€§äžå€«ãã§ã¯ãªããã ãã
ãã ãä»åŸã®ç 究次第ã§ã¿ããªãæããããªæå³ã§ã®ç¹å¹è¬ã«ãªããããããªãã
ç±³ã¡ã«ã¯ç€Ÿã®çµå£æãŠã€ã«ã¹è¬ãã¢ã«ããã©ãã«ãã®èšåºè©Šéšçµæãè¯å¥œã§ãæ¿èªã«åãåããŠããããã§ããã¿ããã«ã®ããã«ãªãã®ã§ããããïŒ
æ¬æ¥ã³ãã蚺çã¯17æãŸã§ã§ã
å蚺åžæã®æ¹ã¯DMãLINEã§ãé£çµ¡äžãã
æ¬æ¥ã³ãã蚺çã¯17æãŸã§ã§ã
å蚺åžæã®æ¹ã¯DMãLINEã§ãé£çµ¡äžãã
èãã¿ãããªååã ïœ
ãã©ãã£ã±ãæäœã«ã¯ãã«çæ³ãšäžç·ã§ããŠã£ã«ã¹ãå¢æ®ãããªããããã®ããã§ãæ»æ» ãããããããããªããããŸã ãŸã é£ãããª
ãã©ãã£ã±ãæäœã«ã¯ãã«çæ³ãšäžç·ã§ããŠã£ã«ã¹ãå¢æ®ãããªããããã®ããã§ãæ»æ» ãããããããããªããããŸã ãŸã é£ãããª
ã¢ã«ããã©ãã«ãååãããã
ã¡ã«ã¯ç€Ÿã®ã³ããæ²»çè¬ãæåŸ
ã§ããããªçµæ ^^
ãã£ã¡ãæå ±ã
ãããæ¥å¹Žã«ã¯ã³ããçŠçµæ¯ãããããªã
ãããæ¥å¹Žã«ã¯ã³ããçŠçµæ¯ãããããªã
å瀟ã¯ä»åŸ2é±éã®ãã¡ã«ãã¢ã¡ãªã«ã§ã¢ã«ããã©ãã«ã®ç·æ¥äœ¿çšèš±å¯ãç³è«ãããšããŠããã
ïŒãã®è¬ã¯ããšããšã€ã³ãã«ãšã³ã¶æ²»çè¬ãšããŠéçºããããã®ã§ããŠã€ã«ã¹ã®éºäŒåã«å¯ŸããŠè€è£œãšã©ãŒãçããããå¢æ®ãé²ãããèšèšãããŠããã
ã¢ã«ããã©ãã«ã£ãŠãåççã«ã¯ãã¢ãã¬ã³ãšåãã§ããã
ã¢ãã¬ã³ããå¹ãã®ã§ããããïŒ
ã¢ã«ããã©ãã«ã£ãŠãåççã«ã¯ãã¢ãã¬ã³ãšåãã§ããã
ã¢ãã¬ã³ããå¹ãã®ã§ããããïŒ
ç·æ¥äœ¿çšç³è«ãšã¯ãèªå¯åã«äœ¿çšåºæ¥ãã³ãããŠã€ã«ã¹ææç察ç倧統é 什(çºä»€è
ïŒïŒä»£ã¢ã¡ãªã«å€§çµ±é )ã«äŸãç©ã§ãããã
å°ã³ããã¯ã¯ãã³ãç·æ¥äœ¿çšç¹äŸæªçœ®ãååœã§å»ããŠããŸãã
å°ã³ããã¯ã¯ãã³ãç·æ¥äœ¿çšç¹äŸæªçœ®ãååœã§å»ããŠããŸãã
æ¥æ¬ã¯ãã¯ã¯ãã³åæ§
ãã®æ²»çè¬ã«ã€ããŠã
ç¹äŸæ¿èªããã®ã§ããããâ
ãã®æ²»çè¬ã«ã€ããŠã
ç¹äŸæ¿èªããã®ã§ããããâ
çµå±ãæ©æçºèŠããæ©ææ²»çãã倧ååã§ããäºã«å€ãããªãèš³ã§ãããããããžãã£ããªå ±åããã£ããšããŠããæ¥æ¬ã§ã¯ããŒãã«é«ããã ããª...
ã¡ã«ã¯ããçµå£æ²»çè¬ã§ãã®ã§
æ¥é±æã€ã³ããã¯ã¯ãã³æã¡ããç¡ãã§ã
ãŸãŒåæ¥é±æ±äº¬ã«åºåŒµãªã®ã§
æã£ãŠãããã»ãããããšæã£ãŠãŸãã
å¯åå¿ãæãã§ã((((ïŒïŸÐïŸ)))))))
æ¥é±æã€ã³ããã¯ã¯ãã³æã¡ããç¡ãã§ã
ãŸãŒåæ¥é±æ±äº¬ã«åºåŒµãªã®ã§
æã£ãŠãããã»ãããããšæã£ãŠãŸãã
å¯åå¿ãæãã§ã((((ïŒïŸÐïŸ)))))))
æ°åã³ãããŠã€ã«ã¹ææçCOVID-19çµå£æ²»çè¬ãã¢ã«ããã©ãã«ã
ã¡ã«ã¯
èšåºè©Šéš
ââŠçºçããæ©ã段éã§æçšããå¿ èŠãããããšã瀺ãããŠããããã§ã«é床ã®COVID-19ã§å ¥é¢ããŠããæ£è ã察象ãšããåæç 究ã§ã¯ãäžæ¬æãªçµæãšãªããç 究ã¯äžæ¢âŠâ
ã¡ã«ã¯
èšåºè©Šéš
ââŠçºçããæ©ã段éã§æçšããå¿ èŠãããããšã瀺ãããŠããããã§ã«é床ã®COVID-19ã§å ¥é¢ããŠããæ£è ã察象ãšããåæç 究ã§ã¯ãäžæ¬æãªçµæãšãªããç 究ã¯äžæ¢âŠâ
ã¡ã«ã¯ã®ã¢ã«ããã©ãã«ãæ瞟ãããã®ã§èšåºè©Šéšãæ©æçµäºã«ãªã£ããšã®ããšã§ãæåŸ
ã§ããããªæãã§ãããæäœã«ã¯ãã«ãšå¯Ÿè±¡ã¯åããããªæãã§ããã飲ã¿è¬ã§ãããšããããšã¯å€§ããã§ããçå®ã«ã³ãã察çã®éžæè¢ãå¢ããŠããŠããããã§ãã
ã¯ã¯ãã³ã«ç¶ããŠæ²»çè¬ããããªãå€å ãåãŸã£ãŠããŸãããããã£ãšã ãªãå€ç°æ ªæ¬¡ç¬¬ã ãã©ãä»å¹Žæ«ããããããã£ããæ»ã£ãŠãã2022幎ã¯äººé¡æŽ»åã®åŸ©æŽ»ã®å¹Žãã«ãªããããªæ°ãããŠãããæ¥å¹Žã¯æµ·å€è¡ããã
è¬ãè¿œãã€ããŠããã
â
米補è¬äŒç€Ÿãéçºäžã®æ°åã³ããã®çµå£æ²»çè¬ãã¢ã«ããã©ãã«ããèšåºè©Šéšã®äžéçµæã§å ¥é¢ãæ»äº¡ãªã¹ã¯ãçŽåæžã§ããããšã瀺ãããã
èŠå¶åœå±ã«æ¿èªãããã°ãã¢ã«ããã©ãã«ã¯COVID-19ã®åã®çµå£æãŠã€ã«ã¹è¬ãšãªãã
â
米補è¬äŒç€Ÿãéçºäžã®æ°åã³ããã®çµå£æ²»çè¬ãã¢ã«ããã©ãã«ããèšåºè©Šéšã®äžéçµæã§å ¥é¢ãæ»äº¡ãªã¹ã¯ãçŽåæžã§ããããšã瀺ãããã
èŠå¶åœå±ã«æ¿èªãããã°ãã¢ã«ããã©ãã«ã¯COVID-19ã®åã®çµå£æãŠã€ã«ã¹è¬ãšãªãã
ã¢ãã¬ã³ãã ãã§
ãããããã£ãŠããã«ãã¢ã¡ãªã«ã ãªã
ã¢ã¹ãã©ãŒãã«ãããŸã èªããŠãªãã£ãŠã®ãããªããã
çµ±èšãåã£ãŠã¿ãªããšå¹ãç®ãããããªãçšåºŠã§ã¯
éåžžã¯è¬äºå¹æãªããšãã å¹ããŠãããšã¯èšããªããã ãw
ãããããã£ãŠããã«ãã¢ã¡ãªã«ã ãªã
ã¢ã¹ãã©ãŒãã«ãããŸã èªããŠãªãã£ãŠã®ãããªããã
çµ±èšãåã£ãŠã¿ãªããšå¹ãç®ãããããªãçšåºŠã§ã¯
éåžžã¯è¬äºå¹æãªããšãã å¹ããŠãããšã¯èšããªããã ãw
ãã©ã»ãã§æ»äº¡ãå
¥é¢æ£è
14.1%
åæããŠæ²»éšã«åå ãããšã¯æããã ãã©
è²ããªè¬ãåœããåã«é£²ãã§ããã©è¬ãšã¯åœã§å®æããŠãããã®âŠã§ããâŠ
åæããŠæ²»éšã«åå ãããšã¯æããã ãã©
è²ããªè¬ãåœããåã«é£²ãã§ããã©è¬ãšã¯åœã§å®æããŠãããã®âŠã§ããâŠ
ã¯ã¯ãã³ããçµå£æ²»çè¬ãžé²ãã§ããããšãå¬å Žã«åæ¡æ£ã®å¯èœæ§ããããªãæ©ãã«æ¿èªãšå®çžŸçµãã§ããã°ãããããç¥ããŸãããâºïž
èšåºè©Šéšã¯ç±³è£œè¬äŒç€Ÿã¡ã«ã¯ãå®æœããé å€åã®COVID-19ã®çµå£æ²»çè¬ãã¢ã«ããã©ãã«ãã1æ¥2åæéçºäžã®æ°åã³ãããŠã€ã«ã¹ææçCOVID-19ã®çµå£æ²»çè¬ãã¢ã«ããã©ãã«ãã§ãå
¥é¢ãæ»äº¡ãªã¹ã¯ãçŽåæžã§ããããšããèšåºè©Šéšã®äžéçµæã§ç€ºããã
ã¢ã«ããã©ãã«ã ããã§ã
èªç©ºæ ªã芳å
æ ªã«ã¯è¯ããã¥ãŒã¹ã§ãããããŒã€ã³ã°ã®å«ã¿æã20äžã»ã©ããã®ã§ãåŸ
ã¡é ããã§ãã
ããã®è¬ã¯ããšããšã€ã³ãã«ãšã³ã¶æ²»çè¬ãšããŠéçºããããã®ã§ããŠã€ã«ã¹ã®éºäŒåã«å¯ŸããŠè€è£œãšã©ãŒãçããããå¢æ®ãé²ãããèšèšãããŠããã
ãã¢ã«ããã©ãã«ã
èšåºè©Šéšã®çµæã§ã¯ãå¹æãçºæ®ããã«ã¯ãçºçããæ©ã段éã§æçšããå¿ èŠãããããšã瀺ãããŠããã
ãã§ã«é床ã®COVID-19ã§å ¥é¢ããŠããæ£è ã察象ãšããåæç 究ã§ã¯ãäžæ¬æãªçµæãšãªããç 究ã¯äžæ¢ãããã
èšåºè©Šéšã®çµæã§ã¯ãå¹æãçºæ®ããã«ã¯ãçºçããæ©ã段éã§æçšããå¿ èŠãããããšã瀺ãããŠããã
ãã§ã«é床ã®COVID-19ã§å ¥é¢ããŠããæ£è ã察象ãšããåæç 究ã§ã¯ãäžæ¬æãªçµæãšãªããç 究ã¯äžæ¢ãããã
ãã¢ã«ããã©ãã«ã
ãã®æ²»çæ³ã¯ããŠã€ã«ã¹ã®å€åŽã«ããã¹ãã€ã¯ã¿ã³ãã¯è³ªãæšçãšããå€ãã® ã¯ã¯ãã³ãšã¯ç°ãªãããŠã€ã«ã¹ãèªåèªèº«ã®ã³ããŒãäœãéã«äœ¿ãé µçŽ ãæšçãšããããšã§å¹æãçºæ®
ä»åŸçºçããæ°ããªå€ç°æ ªã«å¯ŸããŠãåæ§ã«æå¹ãªã¯ã
ãã®æ²»çæ³ã¯ããŠã€ã«ã¹ã®å€åŽã«ããã¹ãã€ã¯ã¿ã³ãã¯è³ªãæšçãšããå€ãã® ã¯ã¯ãã³ãšã¯ç°ãªãããŠã€ã«ã¹ãèªåèªèº«ã®ã³ããŒãäœãéã«äœ¿ãé µçŽ ãæšçãšããããšã§å¹æãçºæ®
ä»åŸçºçããæ°ããªå€ç°æ ªã«å¯ŸããŠãåæ§ã«æå¹ãªã¯ã
æ£è
775人察象èšåºè©Šéš
ãã¢ã«ããã©ãã«ã
ã»æäžæ£è ã§ãå ¥é¢ãå¿ èŠã«ãªã£ãã®ã¯7.3ïŒ
ã»ãã©ã»ãïŒåœè¬ïŒæäžæ£è ã§ã¯ã14.1%ãå ¥é¢
ã»æäžæ£è ã«æ»è ãªãã
ã»ãã©ã»ãæäžæ£è ã8人ãåŸã«COVID-19ã§æ»äº¡
ãã¢ã«ããã©ãã«ã
ã»æäžæ£è ã§ãå ¥é¢ãå¿ èŠã«ãªã£ãã®ã¯7.3ïŒ
ã»ãã©ã»ãïŒåœè¬ïŒæäžæ£è ã§ã¯ã14.1%ãå ¥é¢
ã»æäžæ£è ã«æ»è ãªãã
ã»ãã©ã»ãæäžæ£è ã8人ãåŸã«COVID-19ã§æ»äº¡
ãã¢ã«ããã©ãã«ã
èŠå¶åœå±ã«æ¿èªãããã°ãCOVID-19ã®åã®çµå£æãŠã€ã«ã¹è¬ãšãªãã
ãã®è¬ã¯ããšããšã€ã³ãã«ãšã³ã¶æ²»çè¬ãšããŠéçºããããã®ã§ããŠã€ã«ã¹ã®éºäŒåã«å¯ŸããŠè€è£œãšã©ãŒãçããããå¢æ®ãé²ãããèšèšãããŠããã
èŠå¶åœå±ã«æ¿èªãããã°ãCOVID-19ã®åã®çµå£æãŠã€ã«ã¹è¬ãšãªãã
ãã®è¬ã¯ããšããšã€ã³ãã«ãšã³ã¶æ²»çè¬ãšããŠéçºããããã®ã§ããŠã€ã«ã¹ã®éºäŒåã«å¯ŸããŠè€è£œãšã©ãŒãçããããå¢æ®ãé²ãããèšèšãããŠããã
COVID-19ã®çºçãæè¿èšºæãããæ£è
ã«å¯Ÿã
é å€åã®COVID-19ã®çµå£æ²»çè¬ãã¢ã«ããã©ãã«ãã1æ¥2åæäž
çµæãéåžžã«è¯å¥œã ã£ãããšãããå€éšã¢ãã¿ãŒããèšåºè©Šéšã®æ©æçµäºãèŠè«
ã¡ã«ã¯ç€Ÿã¯ä»åŸ2é±éã®ãã¡ã«ãã¢ã¡ãªã«ã§ã¢ã«ããã©ãã«ã®ç·æ¥äœ¿çšèš±å¯ãç³è«ããã
é å€åã®COVID-19ã®çµå£æ²»çè¬ãã¢ã«ããã©ãã«ãã1æ¥2åæäž
çµæãéåžžã«è¯å¥œã ã£ãããšãããå€éšã¢ãã¿ãŒããèšåºè©Šéšã®æ©æçµäºãèŠè«
ã¡ã«ã¯ç€Ÿã¯ä»åŸ2é±éã®ãã¡ã«ãã¢ã¡ãªã«ã§ã¢ã«ããã©ãã«ã®ç·æ¥äœ¿çšèš±å¯ãç³è«ããã
米補è¬äŒç€Ÿãéçºäžã® ã®çµå£æ²»çè¬ãã¢ã«ããã©ãã«ãã§ãå
¥é¢ãæ»äº¡ãªã¹ã¯ãçŽåæžã§ããããšããèšåºè©Šéšã®äžéçµæã§ç€ºãããã
æ©å£èšèïŒ
ã³ãããŠã£ã«ã¹é£²ã¿è¬ã®æ²»çè¬
ã¢ã«ããã©ãã«
ã¢ã«ããã©ãã«
ã¢ã«ããã©ãã«
èšããŸããð
ã³ãããŠã£ã«ã¹é£²ã¿è¬ã®æ²»çè¬
ã¢ã«ããã©ãã«
ã¢ã«ããã©ãã«
ã¢ã«ããã©ãã«
èšããŸããð
ãã¢ã«ããã©ãã«ã
ã®çµå£æ²»çè¬ãå ¥é¢ã»æ»äº¡ãªã¹ã¯ãåæž ç±³è£œè¬äŒç€Ÿãç·æ¥äœ¿çšç³è«ãž
ã®çµå£æ²»çè¬ãå ¥é¢ã»æ»äº¡ãªã¹ã¯ãåæž ç±³è£œè¬äŒç€Ÿãç·æ¥äœ¿çšç³è«ãž
-ã¢ã«ããã©ãã«ãæäžãããæ£è
ã§ãå
¥é¢ãå¿
èŠã«ãªã£ãã®ã¯7.3ïŒ
-ããã«å¯Ÿãããã©ã»ãïŒåœè¬ïŒãæäžãããæ£è ã§ã¯ã14.1%ãå ¥é¢
-ã¢ã«ããã©ãã«ãæäžãããæ£è ã®äžã«æ»è ã¯åºãªãã£ããããã©ã»ããæäžãããæ£è ã®ãã¡ã8人ãåŸã«COVID-19ã§æ»äº¡
ã§ããé«ãïŒ
-ããã«å¯Ÿãããã©ã»ãïŒåœè¬ïŒãæäžãããæ£è ã§ã¯ã14.1%ãå ¥é¢
-ã¢ã«ããã©ãã«ãæäžãããæ£è ã®äžã«æ»è ã¯åºãªãã£ããããã©ã»ããæäžãããæ£è ã®ãã¡ã8人ãåŸã«COVID-19ã§æ»äº¡
ã§ããé«ãïŒ
æåŸ
ããŠãã
ã ããã€ã³ãã«ãšã³ã¶ã®ãŸãã«ãŒã¶ã¿ããã«ãã䜿ããªããªãè¬ã«ãªããªãããšãé¡ã
ã ããã€ã³ãã«ãšã³ã¶ã®ãŸãã«ãŒã¶ã¿ããã«ãã䜿ããªããªãè¬ã«ãªããªãããšãé¡ã
ã¡ã«ã¯ã®ã¢ã«ããã©ãã«ã¯ãã€ã³ãã«ãšã³ã¶æ²»çè¬ãšããŠéçºããããã®ãã³ãããŠã€ã«ã¹ã®éºäŒåã«å¯ŸããŠè€è£œãšã©ãŒïŒé
µçŽ ãæšçïŒãçããããå¢æ®ãé²ããŸãã2é±éã®ãã¡ã«ç±³åœã§ç·æ¥äœ¿çšèš±å¯ãç³è«ããäºå®ã§ãã
ããŸãå®çŸããŠã»ãã
äžäººåœãã8äžåâŒïžæ¢åã®ã€ãã«ã¡ã¯ãã³çã䜿ããªãã®ã¯å²ãããªãããã§ã¯âã¯ã¯ãã³ã®æ¬¡ã¯æ°è¬âŠèšç»éãã§ããð±ð±ð±
ðððððððððððð
ðððððððððððð
ç±³åœã¡ã«ã¯ç€Ÿãã¢ãã«ãã©ãã«ã
ã
ã
æ°åãŠã€ã«ã¹ã®çµå£æ²»çè¬ã補è¬äŒç€Ÿãç·æ¥äœ¿çšç³è«ãž
å®çšåã«æåŸ
ã¯èšãããããããæ©ææäžãå¿
èŠãªã®ãããã ããã©ã»ãæäžã§æ»äº¡ã£ãŠããªãããããããããªããã©ã»ããããªãæ¬ç©ãªãæãããããšæããšã
ãçºçããæ©ã段éã§æçšããå¿
èŠãããããšã瀺ãããŠãããæãŠã€ã«ã¹è¬ã ãšãããã¡ãªãæ©ãã®PCRæ€æ»ã§ç¹å®ããŠæ²»çãåããããäœå¶ãå¿
èŠãšãªãã®ã§ã¯